A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathwayHong Zhao, Jianqiang Cai|Oncotarget|2015Cited by 152
AHR mediates the aflatoxin B1 toxicity associated with hepatocellular carcinomaQing Zhu, Yuchen Jiao, Mo Li et al.|Signal Transduction and Targeted Therapy|2021Cited by 122